DICERNA PHARMACEUTICALS H-1B Visa Sponsorship & Salary Data

The median H-1B salary at DICERNA PHARMACEUTICALS is $109,200, based on 37 certified filings from FY 2020 to FY 2025. This is 9% lower than the national H-1B median salary of $120,000. Compensation at DICERNA PHARMACEUTICALS reflects their market positioning, with entry-level roles starting around $90,154 and senior positions reaching $155,000 or higher. These figures represent base salaries in LCA filings and may not include bonuses, equity grants, or other compensation common at large employers.

Salaries at DICERNA PHARMACEUTICALS range from $75,000 at the 10th percentile to $155,000 at the 90th percentile, showing a $80,000 spread across experience levels and roles. The 25th percentile is $90,154 and the 75th percentile is $130,410.

Yes, DICERNA PHARMACEUTICALS actively sponsors H-1B visas and has been a consistent participant in the H-1B program. They have filed 38 H-1B labor condition applications from FY 2020 to FY 2025, demonstrating ongoing commitment to hiring international talent. With 37 certified applications and a 0% denial rate, DICERNA PHARMACEUTICALS maintains a strong track record for H-1B sponsorship. The company sponsors positions across multiple job categories and locations, making them a viable option for professionals seeking H-1B visa sponsorship.

In the most recent fiscal year (FY 2025), DICERNA PHARMACEUTICALS filed 5 H-1B applications, with 5 certified and 0 denied. Over 6 years of data, DICERNA PHARMACEUTICALS has consistently demonstrated commitment to H-1B sponsorship.

Note: These are Labor Condition Applications (LCAs) filed with the Department of Labor, which is a prerequisite for H-1B petitions. The actual number of H-1B petitions filed with USCIS may differ.

DICERNA PHARMACEUTICALS's LCA (Labor Condition Application) denial rate is 0%, with 0 out of 38 applications denied across all years. This translates to a 100.0% certification rate, which indicates how successfully the company prepares and files H-1B applications. A lower denial rate suggests better compliance with Department of Labor requirements, proper wage documentation, and accurate job classification. Prospective H-1B applicants should consider this approval rate alongside other factors like salary, job role, and location when evaluating DICERNA PHARMACEUTICALS as a potential H-1B sponsor.

This is an excellent approval rate, indicating DICERNA PHARMACEUTICALS has strong H-1B sponsorship practices and typically meets DOL requirements. Applicants can feel confident in the company's H-1B track record.

DICERNA PHARMACEUTICALS sponsors H-1B visas for various specialty occupation positions requiring at least a bachelor's degree. Based on 37 certified filings, the most commonly sponsored job titles reflect the company's primary business functions and talent needs. These positions typically require specialized knowledge in fields like technology, engineering, finance, or scientific research. Understanding which roles DICERNA PHARMACEUTICALS most frequently sponsors can help job seekers target their applications effectively.

Most common H-1B job titles at DICERNA PHARMACEUTICALS:

The most frequently sponsored role is Research Scientist I with 6 filings at a median salary of $104,500. This is followed by Senior Research Associate (6 filings) and Research Scientist.

DICERNA PHARMACEUTICALS's H-1B positions are distributed across multiple U.S. locations, with concentration in major metropolitan areas and tech hubs. Geographic distribution often reflects company office locations, client sites, and regional market demands. Location significantly impacts H-1B salary due to varying cost of living and local wage requirements. Understanding where DICERNA PHARMACEUTICALS sponsors H-1B workers can help candidates target specific offices and negotiate appropriate compensation for each market.

Top DICERNA PHARMACEUTICALS H-1B locations:

The largest H-1B hub for DICERNA PHARMACEUTICALS is Lexington, MA with 36 filings at a median salary of $109,200. The highest-paying location is Boulder, CO at $130,000 median. Salaries range from $109,200 to $130,000 across office locations.

DICERNA PHARMACEUTICALS's median H-1B salary has increased by +12% from FY 2020 ($97,846) to FY 2025 ($109,200). Tracking salary trends over time reveals how DICERNA PHARMACEUTICALS adjusts compensation to remain competitive in the H-1B labor market. Salary growth typically reflects inflation adjustments, increased demand for specialized skills, and evolving prevailing wage requirements. These historical trends can help applicants understand future salary expectations and negotiate appropriately when considering H-1B opportunities at DICERNA PHARMACEUTICALS.

Year-by-year breakdown:

• FY 2021: $109,978 (5 certified)
• FY 2022: $88,800 (8 certified)
• FY 2023: $120,000 (6 certified)
• FY 2024: $138,600 (9 certified)
• FY 2025: $109,200 (5 certified)

DICERNA PHARMACEUTICALS has maintained steady salary growth for H-1B positions over this period.

DICERNA PHARMACEUTICALS primarily files H-1B applications at Wage Level II, accounting for 41% of their filings. DOL wage levels range from Level I (entry-level, 17th percentile of local wages) to Level IV (expert, 67th percentile). Wage level determines both salary requirements and, under recent H-1B rules, lottery selection priority. Higher wage levels receive preference in the H-1B lottery, making DICERNA PHARMACEUTICALS's wage level distribution an important factor for prospective applicants assessing their chances of H-1B selection.

With 84% of positions at Level II or higher, DICERNA PHARMACEUTICALS typically offers competitive wages above entry-level. Higher wage levels receive priority in the H-1B lottery.

DICERNA PHARMACEUTICALS's median H-1B salary of $109,200 is 9% lower than the national H-1B median of $120,000 across all employers and industries. This comparison provides context for evaluating DICERNA PHARMACEUTICALS's competitiveness in attracting H-1B talent. Keep in mind that industry, location, and job function significantly impact salary levels. Tech companies and financial institutions typically offer higher H-1B salaries than other sectors, while salaries in major metros like San Francisco and New York exceed those in smaller markets. Compare DICERNA PHARMACEUTICALS's offerings with similar companies in your field for a more accurate assessment.

DICERNA PHARMACEUTICALS's H-1B salaries are competitive with industry averages. The 37 total filings indicate active H-1B sponsorship.

Recent H-1B rule changes have increased filing fees and introduced wage-level prioritization in the lottery. DICERNA PHARMACEUTICALS files 16% of positions at Level I, which may face more lottery competition under wage-level prioritization rules.

With 37 certified filings, DICERNA PHARMACEUTICALS invests significantly in H-1B sponsorship. The company's 0% denial rate suggests strong compliance with H-1B requirements and documentation standards.

Note: H-1B regulations are subject to change. Fees shown are estimates based on 2024 USCIS fee schedules. Actual costs may vary based on company size, premium processing, and future rule changes.